Latest Anastrozole Stories
A combination of drugs that target estrogen production significantly reduced the number of tobacco carcinogen-induced lung tumors in mice, according to results from a preclinical study.
A combination of drugs that target estrogen production significantly reduced the number of tobacco carcinogen-induced lung tumors in mice.
Why do so many postmenopausal women who are treated for estrogen-sensitive breast cancer quit using drugs that help prevent the disease from recurring?
Everolimus in combination with exemestane has shown promise for the treatment of breast cancer.
Post-menopausal women with hormone receptor-positive metastatic breast cancer may have a new treatment option that could lengthen their lives.
Changing the order in which two drugs are taken significantly extended the lives of women with metastatic breast cancer, a study has found.
Researchers have proven the continuing effectiveness of treating patients with estrogen receptor-positive premenopausal breast cancer with adjuvant zoledronic acid in addition to adjuvant endocrine treatment including ovarian function suppression.
Results from the longest-running trial comparing tamoxifen with the aromatase inhibitor letrozole show unequivocally that letrozole has withstood the test of time and continues to prevent breast cancer recurrences and reduce the risk of death in post-menopausal women with hormone receptor-positive early breast cancer.
- A poem in which the author retracts something said in an earlier poem.